The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many businesses slipped in the eyes of their investors.
Health care remains a highly profitable industry. But the biggest companies didn’t meet the lofty expectations of shareholders, dragging down their stocks.
A few CEOs lost their jobs as a result, with some like Karen Lynch of CVS Health securing tens of millions of dollars on their way out. But many who stayed were rewarded even more. Compensation data show that the biggest pay packages usually come down to tenure: If someone stays long enough in the corner office, and the company doesn’t implode, their pot of gold grows larger.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
